Rachid Izzar - 10 Feb 2025 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Head of Global Product Strat.
Signature
/s/ Samuel Ntonme, attorney-in-fact for Rachid Izzar
Issuer symbol
BIIB
Transactions as of
10 Feb 2025
Transactions value $
-$63,430
Form type
4
Filing time
12 Feb 2025, 17:40:05 UTC
Previous filing
11 Feb 2025
Next filing
16 Jul 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Options Exercise $0 +1,515 +20% $0 8,998 10 Feb 2025 Direct F1
transaction BIIB Common Stock Tax liability -$63,430 -445 -4.9% $142.54 8,553 10 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Options Exercise $0 -1,515 -100% $0 0 10 Feb 2025 Common Stock 1,515 $0 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Total adjusted to reflect transfer of shares to the reporting person's former spouse pursuant to a Domestic Relations Order.
F2 The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022.